在预警阶段进行干预以预防偏头痛:药物治疗的前景
Nazia Karsan1,2, Peter J Goadsby3,4,5
1Headache Group, Wolfson SPaRC, Institute of Psychiatry, Psychology and Neuroscience, Wellcome Foundation Building, King's College London, Denmark Hill, London, SE5 9PJ, UK.
CNS drugs
|May 31, 2024
概括
偏头痛的发作可以比以前想象的更早地治疗,甚至在头痛疼痛开始之前. 针对素基因相关 (CGRP) 的新疗法在偏头痛症状升级之前有望预防偏头痛症状.
科学领域:
- 神经学和神经科学 神经学和神经科学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 偏头痛是一种常见的神经系统疾病,导致头痛和感官敏感性的致残性发作.
- 当前的急性治疗方法,如三药,在头痛阶段早期启动时最有效,但这对患者来说可能是具有挑战性的.
- 特里普坦有其局限性,包括对血管疾病和老年人的禁忌,并且可能对所有患者都不有效.
研究的目的:
- 审查关于早期干预偏头痛发作的历史和新出现的数据,特别是在监测前阶段.
- 探索可以在头痛发作之前使用的治疗点和药物,以预防与攻击相关的发病率.
- 为满足当前疗法服务不足的患者的治疗需求.
主要方法:
- 关于早期偏头痛干预的历史研究 (多佩里,纳拉特里普坦,二甲胺) 的综述.
- 对新的向偏头痛治疗方法的新数据的分析,特别是素基因相关 (CGRP) 受体对抗剂 (gepants).
- 综合证据支持前监测阶段作为治疗机会.
主要成果:
- 早期的研究表明,在头痛发作之前进行干预可能有好处,尽管存在方法上的限制.
- 关于CGRP受体对抗剂的新兴数据显示,早期干预策略的结果令人鼓舞.
- 预兆期,以头痛前的无痛症状为特征,为预防性治疗提供了一个窗口.
结论:
- 在偏头痛发作前监测阶段进行干预是防止头痛发作和减少整体发作负担的有希望的策略.
- 新的治疗方法,如,为早期偏头痛干预提供了新的机会.
- 进一步的研究和早期干预策略的临床应用是有必要的,以改善患者的治疗结果.
相关概念视频
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:26Cholinergic Antagonists: Therapeutic Uses
741
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
741
01:26Drug Administration and Therapy Phases: Overview
448
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
448
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
194
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
194
01:24Cholinergic Antagonists: Pharmacokinetics
432
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
432